Welcome to Pedagogy   |   Sign In

Affordable Steroids Could Reduce Some COVID-19 Deaths

Steroids have been found to reduce the risk of death in critically ill coronavirus patients.

You’d think a robust immune system would be an awfully good thing to have if you’re battling COVID-19—and much of the time it is. But in the most extreme cases—the ones the World Health Organization (WHO) labels as “severe and critical,” denoting the most extremely ill, typically hospitalized patients, with the highest risk of death—the system meant to protect the body from disease can make things worse, leading to inflammation and other damage to the lungs, which in turn can result in an often fatal case of acute respiratory distress syndrome (ARDS).

In June, a single large study of more than 6,200 patients found that corticosteroids, a class of drugs that reduce inflammation, could prevent at least some cases of coronavirus-related ARDS and the resulting deaths. Today, the WHO confirmed that preliminary report, announcing a new policy, based on a study published in JAMA, calling for the administration of steroids to all patients in the “severe and critical” category, based on findings that the treatment could reduce mortality by slightly more than one third.

The new conclusions were reached through a meta-analysis of seven different studies, each exploring the efficacy of corticosteroids in the most serious cases of COVID-19. The combined sample group from all seven studies included 1,703 severely ill patients, 678 of whom were administered steroids and 1,025 who received ordinary care (which did not include steroids) or a placebo. All of the patients were hospitalized and most were on ventilators. Over the course of 28 days, the death rate was 34% lower among the steroid-treated patients than among those in the control group.



“The consistent findings of benefit in these studies provide definitive data that corticosteroids should be first-line treatment for critically ill patients with COVID-19,” wrote Dr. Hallie Prescott, professor of medicine at the University of Michigan, and Dr. Todd Rice, professor of Medicine at Vanderbilt University, in a JAMA editorial that accompanied the publication of the study.

The findings come with limitations. Steroids should not be used prophylactically in people with less serious cases of COVID-19, since the very suppression of immune system action that helps prevent or treat ARDS would only worsen the condition of people whose immune systems are functioning as they should, battling the virus without damaging the lungs. WHO also warned against “indiscriminate use” of any anti-COVID-19 therapeutic, including steroids, for fear of creating global shortages.

One new therapy that is 34% effective against one subset of cases of a disease that has sickened nearly 26 million people worldwide is not yet the stuff of victory parades. But in the grinding war against COVID-19, it is an undeniable victory in one important battle.

Original article by time.com.

----------------------------------------------------------------------------------------------------------------------

For those of you interested in learning more about, COVID-19 Pedagogy author Maureen Sullivan has written the courses COVID-19: A Healthcare Pandemic and COVID-19: A Healthcare Pandemic for Post Acute Care.

COVID-19: A Healthcare Pandemic

The purpose of this educational offering is to familiarize the healthcare professional with the issues surrounding COVID-19, a coronavirus that is currently causing a healthcare pandemic. This novel or new coronavirus was identified last year (2019), and is currently causing increasing numbers of illness and death worldwide. As this viral infection takes a financial, medical, and emotional toll on the worldwide population, it is imperative that all healthcare workers have a basic understanding of the virus, its symptoms, and transmission, and most importantly, what measures can be taken to lower the risk of infection in all areas of work and home.

COVID-19: A Healthcare Pandemic for Post Acute Care

The purpose of this educational offering is to familiarize the healthcare professional with the issues surrounding COVID-19, a coronavirus that is currently causing a healthcare pandemic. This novel or new coronavirus was identified in 2019, and is currently causing illness and death worldwide. As this viral infection takes a financial, medical, and emotional toll on the worldwide population, it is imperative that all healthcare workers have a basic understanding of the virus, its symptoms, and transmission, and most importantly, what measures can be taken to lower the risk of infection in all areas of work and home. The Post Acute Care sector cares for the most vulnerable population and Centers for Medicare and Medicaid Services has specific guidelines for facilities to follow. This course will discuss current treatment options, basic healthcare laws as they relate to public health emergencies, healthcare provider burnout and moral injury as the pandemic persists.

For healthcare professionals wanting to learn more, take a look at our entire catalog on infusion continuing education courses! Click here to access the largest selection of infusion continuing education courses offered online, including discounted course packages and membership option!

Pedagogy's courses are available for purchase by the individual or facility. For individuals, register with us to create your log in and password, click on the course title of interest and then click the Buy Now button. For a complete listing of all our online continuing education courses click here.

For facilities or institutions that would like to purchase education for their entire staff, email sales@pedagogy-inc.com and let us know the course(s) of interest and how many staff members you need to provide education for, and we will be happy to send you a price quote.

Pedagogy Newsletter
Subscribe to Pedagogy's Quarterly Newsletter

Subscribe


Copyright © 2020 Pedagogy, Inc. All Rights Reserved.



Powered by Kentico